|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Processa Pharmaceuticals, Inc. (PCSA) |
|
|
$0.23 0.00 (0.00%) as of 4:30 Fri 1/19
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
10,570,000 |
| Market
Cap: |
2.38(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.182 - $0.835 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Processa Pharmaceuticals is a biopharmaceutical company focused on the development of drug products for patients who have unmet medical need. Co. 's drug pipelines are: PCS499, which is an oral tablet that is an analog of one of the major metabolites of pentoxifylline; PCS12852, which is a potent and 5-hydroxytryptamine 4 receptor agonist; PCS3117, which is an analog of the endogenous nucleoside, cytidine, and an analog of the cancer drug gemcitabine; PCS6422, which is an oral inhibitor of dihydropyrimidine dehydrogenase, the enzyme that metabolizes a common chemotherapy drug known as 5-FU, into inactive metabolites; and PCS11T, which is a lipophilic anti-cancer pro-drug.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
63,000 |
103,000 |
185,000 |
| Total Buy Value |
$0 |
$160,099 |
$192,099 |
$235,286 |
| Total People Bought |
0 |
4 |
4 |
4 |
| Total Buy Transactions |
0 |
6 |
7 |
12 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lin Patrick |
Chief Business - Strategy Off |
• • – |
2023-10-10 |
4 |
A |
$0.21 |
$2,877 |
D/D |
13,700 |
464,535 |
|
- |
|
| Pannu Geraldine |
|
• • – |
2023-10-10 |
4 |
A |
$0.21 |
$945 |
D/D |
4,500 |
57,613 |
|
- |
|
| Young David |
Pres. Research & Development |
• • • |
2023-10-10 |
4 |
A |
$0.24 |
$34,080 |
D/D |
142,000 |
612,424 |
|
- |
|
| Ng George K |
Chief Executive Officer |
• • – |
2023-10-10 |
4 |
A |
$0.25 |
$25,000 |
D/D |
100,000 |
100,000 |
|
- |
|
| Stanker James H |
Chief Financial Officer |
• • – |
2023-10-10 |
4 |
A |
$0.24 |
$5,400 |
D/D |
22,500 |
84,250 |
|
- |
|
| Thompson Virgil |
|
• • – |
2023-06-27 |
4 |
OE |
$0.00 |
$0 |
I/I |
23,636 |
123,849 |
|
- |
|
| Baluch Khoso |
|
• • – |
2023-06-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,455 |
27,955 |
|
- |
|
| Pannu Geraldine |
|
• • – |
2023-06-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,636 |
53,113 |
|
- |
|
| Neal James R |
|
• • – |
2023-06-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,407 |
14,407 |
|
- |
|
| Yorke Justin W |
|
• • – |
2023-06-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,636 |
56,729 |
|
- |
|
| Young David |
President & CEO |
• • • |
2023-06-12 |
4 |
B |
$0.80 |
$32,000 |
D/D |
40,000 |
470,424 |
0.01 |
-26% |
|
| Young David |
President & CEO |
• • • |
2023-04-14 |
4 |
B |
$0.55 |
$10,998 |
D/D |
20,000 |
430,424 |
0.01 |
-28% |
|
| Young David |
President & CEO |
• • • |
2023-04-13 |
4 |
B |
$0.48 |
$9,600 |
D/D |
20,000 |
410,424 |
0.01 |
-23% |
|
| Young David |
President & CEO |
• • • |
2023-04-12 |
4 |
B |
$0.45 |
$9,000 |
D/D |
20,000 |
390,424 |
0.01 |
-20% |
|
| Young David |
President & CEO |
• • • |
2023-04-11 |
4 |
B |
$0.52 |
$10,400 |
D/D |
20,000 |
370,424 |
0.01 |
-18% |
|
| Lin Patrick |
Chief Business - Strategy Off |
• – – |
2023-02-09 |
4 |
A |
$0.80 |
$10,000 |
D/D |
12,500 |
450,835 |
|
- |
|
| Baluch Khoso |
Director |
– • – |
2023-02-09 |
4 |
A |
$0.80 |
$10,000 |
D/D |
12,500 |
12,500 |
|
- |
|
| Floyd Robert Michael |
Chief Operating Officer |
• – – |
2023-02-09 |
4 |
A |
$0.80 |
$8,000 |
D/D |
10,000 |
82,267 |
|
- |
|
| Young David |
President & CEO |
• • • |
2023-02-09 |
4 |
A |
$0.80 |
$15,000 |
D/D |
18,750 |
350,424 |
|
- |
|
| Stanker James H |
Chief Financial Officer |
• – – |
2023-02-09 |
4 |
A |
$0.80 |
$10,000 |
D/D |
12,500 |
61,750 |
|
- |
|
| Yorke Justin W |
Director |
– • – |
2022-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
18,208 |
33,093 |
|
- |
|
| Pannu Geraldine |
Director |
– • – |
2022-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,208 |
29,477 |
|
- |
|
| Thompson Virgil |
Director |
– • – |
2022-12-31 |
4 |
OE |
$0.00 |
$0 |
I/I |
18,208 |
100,213 |
|
- |
|
| Floyd Robert Michael |
Chief Operating Officer |
• – – |
2022-10-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,163) |
72,267 |
|
- |
|
| Floyd Robert Michael |
Chief Operating Officer |
• – – |
2022-10-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
76,430 |
|
- |
|
129 Records found
|
|
Page 2 of 6 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
